Category: Autoimmune
Global Autoimmune
-
Global Immunoglobulin Products Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Immunomodulators Databank Market Report
... segment is expected to be the highest contributor to this market, with $78,020.3 Million in 2020, and is anticipated to reach $151,171.1 Million by 2029, registering a CAGR of 7.67%. Oncology and Respiratory segments collectively ... Read More
-
Blood Testing Market by Type (Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels), Application (Allergies, Autoimmune Diseases, Cancer/Noncancerous Blood Disorders), End-User - Global Forecast 2024-2030
... USD 94.49 billion in 2023 and expected to reach USD 100.02 billion in 2024, at a CAGR 6.34% to reach USD 145.37 billion by 2030. Blood testing is a clinical procedure that involves analyzing a ... Read More
-
Hematology Market Size, Trends, Analysis, and Outlook By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers, Others), By Reagent (Coagulation Reagents, Flow Cytometry Reagents, Immun-hematology Reagents, Others), By Application (Drug Testing, Auto-immune Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-testing, Others), by Country, Segment, and Companies, 2024-2032
... Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-testing, Others), by Country, Segment, and Companies, 2024-2032 The global Hematology market size is poised to register 5.8% growth from 2024 ... Read More
-
In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2024-2032
... US$ 4.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.12% during 2024-2032. In-vivo contract research organizations (CROs) are institutions ... Read More
-
Global Autoimmune Uveitis Market - 2023-2030
... forecast period 2023-2030. A rare but potentially dangerous eye disorder known as autoimmune uveitis is characterized by inflammation of the uvea, the central layer of the eye. Autoimmune uveitis can develop in any area of ... Read More
-
Immunoglobulins Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 2022, and the market is now projected to grow from USD 16.24 billion in 2023 to USD 29.57 billion by 2030, exhibiting a CAGR of 8.9% during the forecast period of 2023-2030. The COVID-19 Pandemic ... Read More
-
Global Autoimmune Disease Diagnosis Market
... during the forecast period. Advancements in Diagnostic Technologies: There's a continuous evolution in diagnostic technologies, including next-generation sequencing (NGS), multiplex assays, and digital pathology, enabling more accurate, sensitive, and efficient detection of autoimmune diseases. Companies ... Read More
-
In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Global Forecast to 2029
... diagnostics market is projected to reach USD 119.4 billion by 2029 from USD 85.2 billion in 2024, at a CAGR of 6.9% during the forecast period. With the rapid growth in the geriatric population globally, ... Read More
-
Antiphospholipid Syndrome Treatment Global Market Report 2024
... End-Users: Hospitals; Homecare; Specialty CentersCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG Antiphospholipid Syndrome Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Monoclonal Antibody (mABs) Therapeutics Market by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
... projected to reach USD 497.5 billion by 2029 from an estimated USD 252.6 billion in 2024, at a CAGR of 14.5% during the forecast period. The driving factors of the monoclonal antibody therapeutics market include ... Read More
-
2024 Global Forecast for Autoimmune Disease Diagnosis Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Autoimmune Drugs Market Size, Trends, Analysis, and Outlook By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital, Pharmacy, Drug Store/Retail Pharmacy, Online), by Region, Country, Segment, and Companies, 2024-2030
... The global Autoimmune Drugs market size is poised to register 6.93% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Drugs ... Read More
-
Therapeutic Vaccines Market Size, Trends, Analysis, and Outlook By Product (Autoimmune Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccines, Others), By Technology (Allogeneic Vaccine, Autologous Vaccine), by Region, Country, Segment, and Companies, 2024-2030
... The global Therapeutic Vaccines market size is poised to register 13.11% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Therapeutic Vaccines ... Read More
-
mAb Biosimilars Market Size, Trends, Analysis, and Outlook By Type (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), By Indication (Oncology, Autoimmune diseases, Others), By End-User (Hospitals, Cancer Treatment centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global mAb Biosimilars market size is poised to register 8.8% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global mAb ... Read More
-
Immunodiagnostics Market Assessment, By Type [Radioimmunoassay, ELISA, Chemiluminescent immunoassay, Fluorescent immunoassay, Lateral flow assay, Rapid Test, Others], By Product [Reagents, Instruments, Software & Services], By Application [Oncology, Endocrinology, Infectious diseases, Allergy, Autoimmune Diseases, Environmental Pollution, Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F
... Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F Global immunodiagnostics market size was valued at ... Read More
-
Vitamin D Therapy Market Size, Trends, Analysis, and Outlook By Route of Administration (Oral, Parenteral), By Purchasing Patterns (Prescription, Over-The-Counter), By Application (Osteoporosis, Muscle Weakness, Autoimmune Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... The global Vitamin D Therapy market size is poised to register 11.85% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Vitamin D ... Read More
-
Immunoassay Market Size, Trends, Analysis, and Outlook By Product (Reagents & Kits, Analyzers Type, Analyzers Purchase Mode), By Technology (ELISA, Chemiluminescence Immunoassay (CLIA), Immunofluorescence assay (IFA), Rapid Tests, ELISpot, Western Blotting, Others), By Specimen (Blood, Saliva, Urine, Others), By Application (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, Others), By End User, Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Banks, Research & Academic Laboratories, Home Care Settings), by Region, Country, Segment, and Companies, 2024-2030
... Saliva, Urine, Others), By Application (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, Others), By End User, Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology ... Read More
-
Point of Care Diagnostics Market Size, Trends, Analysis, and Outlook By Product(Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease , Cardiac Markers, Thyroid, Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030
... Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030 The global Point ... Read More
-
The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Lupus Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency Diseases
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Subcutaneous Immunoglobulins
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
Research Assistance
